The flip side of doxorubicin
Author:
Open Access
- 19 September 2013
- journal article
- editorial
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 14 (9) , 774-775
Abstract
Cardiac toxicity is a major dose-limiting factor for the anthracycline drug doxorubicin. The reasons why doxorubicin causes heart damage are not fully understood, and the manuscript by Wong et al. postulates that inflammatory cytokines released from macrophages or other cell types may play a significant role in the damage process in response to doxorubicin and possibly other chemotherapeutic agents.1 Expression of many cytokines requires activation of both the p38 MAPK and JNK pathways and, additionally, doxorubicin toxicity can be blocked by combined inhibition of both pathways.2,3 The MAP3K responsible for doxorubicin-induced p38 MAPK and JNK activation in keratinocytes was previously shown by these authors to be ZAK.4 ZAK is of note because it can be targeted by FDA approved agents such as nilotinib and sorafenib.4-7Keywords
This publication has 11 references indexed in Scilit:
- Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicinCancer Biology & Therapy, 2013
- Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue SarcomasPLOS ONE, 2012
- Comprehensive analysis of kinase inhibitor selectivityNature Biotechnology, 2011
- Doxorubicin and Sorafenib for Treatment of Advanced Hepatocellular CancerGastroenterology, 2011
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasomeCancer Biology & Therapy, 2011
- NF-κB and STAT3 – key players in liver inflammation and cancerCell Research, 2010
- ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cellsCancer Biology & Therapy, 2010
- Extended kinase profile and properties of the protein kinase inhibitor nilotinibBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivoCancer Biology & Therapy, 2008
- A quantitative analysis of kinase inhibitor selectivityNature Biotechnology, 2008